Physician profile
Gary Robert Gropper
NPI 1164531844
$730.74
in general payments reported to CMS, 2019-2025
14 companies · $88.01 in 2025
The $88.01 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $31.23 · 2021: $77.97 · 2022: $82.90 · 2023: $120 · 2024: $91.02 · 2025: $88.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $190.71 | 2019-2024 | Synthecel |
| Medtronic USA, INC. | $151.96 | 2019-2020 | |
| Medtronic, INC. | $102.53 | 2021-2024 | Synchromedii, Strata |
| Radius Health, INC. | $44.06 | 2021-2022 | |
| Kls-Martin L.P. | $42.84 | 2023-2025 | |
| Misonix INC | $32.40 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $29.87 | 2019-2021 | |
| Integra Lifesciences Corporation | $27.64 | 2019 | |
| Aesculap, INC. | $23.88 | 2025 | Progav 2.0 |
| Saluda Medical Americas, INC. | $21.79 | 2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $21.14 | 2022 | |
| Abbott Laboratories | $17.39 | 2025 | Eterna |
| Bioventus LLC | $13.00 | 2022 | |
| Stryker Corporation | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gropper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.